Financial due diligence
Review of revenue quality, profitability, working capital, indebtedness, cash generation and unusual financial trends.
Research · Due diligence services
Financial due diligence, corporate research, commercial risk and sector intelligence on Indian companies.
We help US businesses and advisers assess Indian companies with greater clarity, through disciplined financial analysis, verifiable corporate research and structured commercial risk reporting. An independent practice, delivered remotely from Jaipur.
Engagements are defined by the records available, the procedures agreed and the boundaries of the report. We offer focused analytical judgement and clear documentation, not generic back-office capacity.
Review of revenue quality, profitability, working capital, indebtedness, cash generation and unusual financial trends.
Review of incorporation, directors, ownership, history, related-party indicators, litigation signals and business reputation.
Evaluation of manufacturing or service counterparties: their financial stability, dependency risks and commercial credibility.
Forecasts, cash-flow scenarios, working-capital models and preliminary valuation analyses for business decisions.
Assessment of hospitals, diagnostics, insurers and health-tech businesses, using sector-specific metrics and operating models.
Company profiles, competitor comparisons, target screens and India-specific briefing materials, supported under confidentiality terms.
We work with US boutique M&A advisers and independent sponsors, search funds and small investment firms, importers and SME buyers, and consulting and accounting firms.
A US buyer is considering an Indian company. We assess earnings sustainability, receivables, debt disclosures and related-party exposure. Specialists handle legal and tax verification.
A US distributor is weighing a lower-cost Indian manufacturer. We check entity background, financial resilience and commercial dependencies, and flag what needs a site visit or third-party confirmation.
A private investor wants clarity on burn rate, runway, revenue quality, concentration risk and forecast assumptions. Ownership and cap-table questions go to qualified advisers.
A healthcare group is evaluating Indian hospitals, diagnostics operators or health-tech partners. We prepare sector benchmarks, operating-model analysis and preliminary partner comparisons.
Illustrative situations, not completed assignments.
Credibility depends on a consistent workflow, traceable sources, explicit assumptions and transparent limitations. Each assignment begins with a written scope and ends with a source-documented, risk-ranked report.
Start with a contained assignment and go deeper where the decision calls for it.
For initial supplier or counterparty screening.
For buyers, advisers and firms considering material exposure.
For acquisitions, joint ventures and strategic partnerships.
Every engagement starts with a written scope covering the target entity, documents and sources, exclusions, schedule and revisions. Site visits, multi-entity assessments and specialist verification are scoped separately.
Our value lies in disciplined analysis, transparent evidence and the clear identification of risks, not in promises of certainty.
Engagements run on written terms covering scope, reliance, limitations and confidentiality. Conflicts are assessed and client information is protected. Please note: this is factual corporate and commercial research. It is not legal or tax advice, a statutory audit, or a securities buy, sell or hold recommendation.
Tell us the decision you need to make and the documents you have. We will respond with a written scope.